Revolutionizing Iron Supplements for Women

A groundbreaking supplement developed by Probi aims to combat iron deficiency specifically among women. This formulation uniquely utilizes probiotics to improve iron absorption, setting it apart in a market often overlooked by traditional products.

Addressing a Critical Need

Women represent a significant portion of the global population yet remain underrepresented in the fields of science and healthcare. According to Mary Farrell, the scientific affairs manager at Probi, there has historically been a lack of products tailored to women’s specific health needs. “We wanted to address that gap,” she stated, emphasizing the importance of developing solutions for issues like iron deficiency.

Target Audience and Iron Deficiency

Iron deficiency anemia is particularly prevalent among women, affecting approximately one in three worldwide. This condition intensifies during critical life stages such as menstruation, pregnancy, and postpartum recovery due to increased iron requirements.

Farrell highlights that traditional iron supplements often lead to gastrointestinal side effects, with up to 78% of users reporting discomfort, which can deter them from ongoing treatment. “One of the major challenges with iron supplements is their harsh impact on the digestive system,” she noted.

Innovative Probiotic Approach

The supplement incorporates the probiotic strain Lactiplantibacillus plantarum 299v (LP299V), which is engineered to enhance iron absorption. This approach not only reduces the required dosage but also helps maintain iron in a bioavailable state, significantly lowering the incidence of unwanted side effects.

Clinical research supports these claims: a recent placebo-controlled trial with 295 subjects revealed that supplementation with LP299V reduced gastrointestinal intolerance from 46.5% to just 13.0%, markedly improving tolerability and adherence to treatment regimens.

Compliance and Ingredients

In formulating this product, Probi also incorporates minimal amounts of iron, vitamin C, and folic acid, fulfilling European regulatory requirements while ensuring the primary benefits are attributed to LP299V. Farrell explained, “The main active component is our probiotic strain, LP299V,” emphasizing its role in enhancing iron absorption and reducing side effects.

Acknowledgement in the Industry

Probi’s efforts to innovate in this field were recently recognized at the NutraIngredients Awards. Farrell expressed that such accolades are significant for a company deeply committed to scientific integrity, stating, “It’s a meaningful recognition, especially for a science-focused company like ours.”

Conclusion

The development of this probiotic-based iron supplement represents a significant advancement in addressing iron deficiency among women. By focusing on both efficacy and tolerability, Probi aims to improve health outcomes, making it easier for women to access essential nutrients without the common drawbacks associated with traditional iron supplementation.